Bank of Montreal
EVLO

Bank of Montreal’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bank of Montreal’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-119
Closed -$24K – 5243
2021
Q1 		$24K Sell
119
-111
-48% -$30.7K ﹤0.01% 3988
2020
Q4 		$56K Buy
230
+134
+140% +$16.6K ﹤0.01% 3895
2020
Q3 		$10K Sell
96
-44
-31% -$4.01K ﹤0.01% 4147
2020
Q2 		$13K Buy
140
+52
+59% +$4.55K ﹤0.01% 4058
2020
Q1 		$6K Sell
88
-90
-51% -$8.57K ﹤0.01% 3654
2019
Q4 		$14K Sell
178
-63
-26% -$7.05K ﹤0.01% 4480
2019
Q3 		$29K Sell
241
-1
-0.4% -$137 ﹤0.01% 3889
2019
Q2 		$43K Buy
242
+77
+47% +$12.4K ﹤0.01% 3773
2019
Q1 		$26K Buy
165
+24
+17% +$4.75K ﹤0.01% 3583
2018
Q4 		$37K Buy
141
+101
+253% +$20.3K ﹤0.01% 3413
2018
Q3 		$9K Buy
40
+38
+1,900% +$9.94K ﹤0.01% 3965
2018
Q2 		$0 Buy
+2
New +$583 ﹤0.01% 4920

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal's EVLO Position: Q2 2021 in Review

Bank of Montreal sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2021, closing a stake of 119 shares — an estimated $24K sold.

Bank of Montreal first reported a position in EVLO in Q2 2018 and held it in 12 quarters. The position peaked at $56K in Q4 2020. 66 funds tracked by Wall St. Rank hold EVLO as of Q2 2021.

  • Bank of Montreal reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 119 Evelo Biosciences, Inc. Common Stock shares in Q2 2021, an estimated $24K.
  • Bank of Montreal first reported a position in Evelo Biosciences, Inc. Common Stock in Q2 2018 and held it in 12 quarters.
  • Bank of Montreal's Evelo Biosciences, Inc. Common Stock position peaked at $56K in Q4 2020.
  • 66 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.